Longevity.Technology

Biotech company Basecamp has raised $140 million to build artificial intelligence trained on biological data. The funding, reported by Longevity.Technology, will support efforts to give AI systems a comprehensive understanding of biology, with potential applications in drug discovery and longevity research. The sizable raise signals continued strong investor appetite for AI applied to the life sciences.